The abstract is read at the publisher; the summary is JClub's.
ACSS2 is a critical metabolic modulator in angiogenic endothelial cells, sustaining acetyl-CoA and glycolysis to support EC proliferation and retinal vascularization.
- Why it matters: Hypoxia-driven glycolytic activation during angiogenesis is not well explained, limiting metabolic targets for controlling pathological vessel growth.
- What they did: The study links ACSS2-mediated acetate-to-acetyl-CoA conversion in angiogenic front ECs to glycolytic flux, using endothelial-specific Acss2 deletion and HIF-1α and GLUT1 readouts.
- The result: ACSS2 loss disrupts pathological angiogenesis and normalizes tumor vasculature, while PDK4 knockdown rescues metabolic and functional defects in ACSS2-deficient ECs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.